SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-15-000278
Filing Date
2015-08-07
Accepted
2015-08-07 14:00:28
Documents
1
Period of Report
2015-08-07

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR THE MONTH OF AUGUST, 2015 nymox6k150804.htm 6-K 7566
  Complete submission text file 0001176256-15-000278.txt   8611
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 151036610
SIC: 2835 In Vitro & In Vivo Diagnostic Substances